Biotech company Moderna, co-founded by HSCI scientist Derrick Rossi, is set to bring a new class of treatments to patients.
Summary
Derrick Rossi’s research into using mRNA as a new kind of therapeutic was initially supported by HSCI seed funding, and gave rise to biotech companyModerna Therapeutics.
Moderna’s public offering of $600 million is the largest ever of a venture-capital-backed biotechnology company, reflecting the potential of its new technology: mRNA therapeutics
Moderna’s success in creating therapies that will benefit patients reflects the crucial role of HSCI in enabling early-stage, high-risk research.
HSCI, a network of the nation’s top stem cell and regenerative medicine researchers, gathers to exchange ideas and forge new collaborations to advance biomedical research.
In a cross-school collaboration, Harvard researchers Steve McCarroll (left) and Kevin Eggan (right) couple stem cell science with genetics and genomics to advance our understanding of human brain illnesses. Their latest project identified mutations that stem cell...
Cambridge, MA, June 16,2016 - The Harvard Stem Cell Institute, three of Harvard’s clinical affiliates, and a biopharmaceutical company have formed a unique collaboration to establish the Boston Autologous Islet Replacement Program (BAIRT) to accelerate a cure for...
Researchers at Harvard Stem Cell Institute suppressed the CAF1 gene to create colonies of induced pluripotent stem cell (iPS cells) at greater speeds and...
In the top image the frog embryo is developing normally. In the bottom image the frog embryo is lacking a head and brain as a result of the suppression of the Notum protein.
Researchers identify a vital protein that can determine head and brain development
Above, one type of hypothalamic neuron created from stem cells. For the first time, researchers have access to these live human neuron types that are involved in everything from the regulation of sleep, to obesity, and...
Fat cells (yellow) descended from transplanted human mesenchymal stem cells (green) inside of a mouse 28 days after a co-transplantation procedure. The red stain shows mouse fat cells. The blue stain shows cell nuclei. (Credit: Juan Melero-Martin, PhD)